Judgment of the General Court of 13 May 2016 — Market Watch v EUIPO — Glaxo Group (MITOCHRON)
(Case T-312/15) 1
(EU trade mark — Opposition proceedings — Application for EU word mark MITOCHRON — Earlier national word mark MIVACRON — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation No 207/2009)
Language of the case: English
Parties
Applicant: Market Watch Franchise & Consulting, Inc. (Freeport, Bahamas) (represented by: J. Korab, lawyer)
Defendant: European Union Intellectual Property Office (represented by: S. Bonne, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervening before the General Court: Glaxo Group Ltd (Brentford, United Kingdom) (represented by S. Malynicz, Barrister, and A. Smith, Solicitor)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 20 March 2015 (Case R 507/2014-2), relating to opposition proceedings between Glaxo Group Ltd and Market Watch Franchise & Consulting, Inc.
Operative part of the judgment
The Court:
1. Dismisses the action;
2. Orders Market Watch Franchise & Consulting, Inc. to pay the costs.
____________1 OJ C 270, 17.8.2015.